Yoshiyuki Takami

Background: Compared with isolated aortic valve replacement (AVR), echocardiographic hemodynamics after Wheat and Bentall procedures, both involving replacement of the proximal ascending aorta with a smaller-diameter graft, have been less thoroughly investigated. Methods: We analyzed 213 patients who received 21 mm or 23 mm aortic bioprostheses (AVR, n = 138; Wheat, n = 43; Bentall, n = 32). Transthoracic echocardiography was performed before and after surgery, and the proximal ascending aortic area (Aa) was assessed using contrast-enhanced computed tomography. Results: The maximal pressure gradient (PG max), derived from the simplified Bernoulli equation, was significantly lower in the Bentall group, whereas pressure recovery (PR), calculated using Voelker's equation, was lower in the AVR group. A smaller Aa was associated with a higher PG max in the AVR group. The Bentall group exhibited significantly lower energy loss (EL). In propensity score-matched analyses to minimize potential confounding factors, the AVR group showed a significantly lower PR and higher EL than the Wheat group; a significantly higher PG max, lower PR, and higher EL than the Bentall group; and a significantly similar PR but lower EL in the Bentall group compared with the Wheat group. Conclusions: Although limited to bioprosthetic valves, caution is warranted when interpreting echocardiographic PG max after AVR in patients with a small ascending aorta. However, overestimation of PG max was not observed in either the Wheat or Bentall groups, even though both demonstrated higher PR and lower EL compared with the AVR group.

OBJECTIVE: To investigate the impact of the discrepancy between the predicted annuloplasty ring size determined by preoperative transesophageal echocardiography and the actual ring size on the outcomes of mitral valve repair (MVr) using primarily the loop technique. METHODS: Among 370 patients who underwent MVr between January 2008 and December 2024, 154 who underwent MVr with the semirigid ring for degenerative disease were involved in this study. Ring size was estimated according to the lengths of A2 and P2 by transesophageal echocardiography. Patients were classified into 3 groups-small, match, and large-based on the discrepancy between the predicted and actual ring sizes. RESULTS: Compared with the other small and match groups, patients in the large group had shorter anterior leaflet length (P = .03), smaller posterior leaflet angle (P = .01) and smaller coaptation depth (P = .03) in the coaptation triangle. There was no significant difference in coaptation length among the 3 groups. The cumulative incidence of mitral regurgitation (MR) grade ≥2 was 0.6% at 1 year, 5% at 5 years, and 24% at 10 years, whereas that of a mean transmitral pressure gradient ≥5 mm Hg were 5%, 13%, and 16%, respectively. Fine-Grey multivariable analysis identified larger posterior leaflet angle after repair as a risk factor for recurrence of MR grade ≥2 and larger body surface area, smaller prosthesis size, and shorter coaptation length as risk factors for functional mitral stenosis. CONCLUSIONS: Size mismatch of the prosthesis ring did not change the coaptation length, late MR recurrence, or functional mitral stenosis after MVr.

This case report describes the management of deep sternal wound infection in a female patient supported with an extracorporeal left ventricular assist device (LVAD) following the Bentall procedure for acute aortic dissection. She developed pleural effusions with pathological communications between the pleural and mediastinal cavities, necessitating continuous drainage. After radical debridement, we applied negative pressure wound therapy (NPWT) with instillation and dwell time (NPWTi-d) to simultaneously drain the pleural cavities and the infected mediastinum. 24 French silicone fluted drain tubes were inserted into both pleural cavities and the pericardial/mediastinal space, with their proximal ends connected to the NPWTi-d sponge. Such simple management allowed for progress in rehabilitation, and the patient underwent a re-Bentall procedure and omentoplasty after 3 months of NPWTi-d therapy. No recurrence of wound infection has been observed in the subsequent 6 months, and the patient remains on LVAD support while awaiting heart transplantation.

Fractional flow reserve (FFR) has been well validated as a modality for evaluating myocardial ischemia, demonstrating the superiority of FFR-guided percutaneous coronary intervention (PCI) over conventional angiography-guided PCI. As a result, the strategy for coronary artery bypass grafting (CABG) is shifting toward FFR guidance. However, the advantage of FFR-guided CABG over angiography-guided CABG remains unclear. While FFR-guided CABG can help avoid unnecessary grafting in cases of moderate stenosis, it may also carry the risk of incomplete revascularization. The limited use of FFR due to the need for hyperemia has led to the development of non-hyperemic pressure ratios (NHPRs). NHPR pullback provides trans-stenotic pressure gradients, which may offer valuable insights for CABG strategies. Recently, computed tomographic coronary angiography (CTCA) has emerged as a non-invasive modality that provides accurate data on lesion length, diameter, minimum lumen area, percentage stenosis, and the volume and distribution of high-risk plaques. With the introduction of FFR-CT, CTCA is now highly anticipated to provide both functional evaluation (of myocardial ischemia) via FFR-CT and anatomical information through serial quantitative assessment. Beyond the diagnostic phase, CTCA, augmented by automatic artificial intelligence, holds great potential for guiding therapeutic interventions in the future.

PURPOSE: Cryoprecipitate has been covered by Japanese national health insurance since 2020 for cardiopulmonary bypass (CPB)-induced hypofibrinogenemia. This study evaluated the clinical efficacy of in-house cryoprecipitate use in patients undergoing CPB. METHODS: A total of 1357 patients were divided into 2 groups before and after cryoprecipitate introduction in February 2020 (Group A, n = 685; Group B, n = 672). Propensity score matching also compared 205 pairs between transfused patients in Group A (Group A', n = 597) and those receiving cryoprecipitate in Group B (Group B', n = 222). RESULTS: Cryoprecipitate was used in 222 patients (37%) in Group B. While overall transfusion rates did not differ significantly, postoperative red blood cell (20% vs 13%, p <0.01) and platelet concentrate (PC) (35% vs 12%, p <0.01) use were significantly lower in Group B. In the matched cohorts, including ~70% undergoing aortic surgery, postoperative PC use was significantly reduced in Group B' (26% vs 18%, p = 0.04). CONCLUSIONS: In-house cryoprecipitate use was associated with reduced postoperative PC transfusion, particularly in aortic surgery involving prolonged CPB and deep hypothermic circulatory arrest. A cryoprecipitate-centered hemostatic strategy, supplementing multiple coagulation factors beyond fibrinogen, may be effective in complex CPB procedures.